Dynamics of Cognitive Impairment in MCI Patients over a Three-Year Period: The Informative Role of Blood Biomarkers, Neuroimaging, and Genetic Factors
Authors:
- Irina MorozovaIMIrina Morozova
- Yana ZorkinaYZYana Zorkina
- Alexander BerdalinABAlexander Berdalin
- Anna IkonnikovaAIAnna Ikonnikova
- Marina EmelyanovaMEMarina Emelyanova
- Elena FedoseevaEFElena Fedoseeva
- Olga AntonovaOAOlga Antonova
- Dmitry GryadunovDmitry Gryadunov
- Alisa AndryushchenkoAAAlisa Andryushchenko
- Valeriya UshakovaVUValeriya Ushakova
- Olga AbramovaOAOlga Abramova
- Angelina ZeltserAZAngelina Zeltser
Open Access
- 28 August 2024
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1883
Abstract
Given the high growth rates of cognitive decline among the elderly population and the lack of effective etiological treatments, early diagnosis of cognitive impairment progression is an imperative task for modern science and medicine. It is of particular interest to identify predictors of an unfavorable subsequent course of cognitive disorders, specifically, rapid progression. Our study assessed the informative role of various risk factors on the dynamics of cognitive impairment among mild cognitive impairment (MCI) patients. The study included patients with MCI (N = 338) who underwent neuropsychological assessment, magnetic resonance imaging (MRI) examination, blood sampling for general and biochemical analysis, APOE genotyping, and polygenic risk score (PRS) evaluation. The APOE ε4/ε4 genotype was found to be associated with a diminished overall cognitive scores initial assessment and negative cognitive dynamics. No associations were found between cognitive changes and the PRS. The progression of cognitive impairment was associated with the width of the third ventricle and hematological parameters, specifically, hematocrit and erythrocyte levels. The absence of significant associations between the dynamics of cognitive decline and PRS over three years can be attributed to the provided suitable medical care for the prevention of cognitive impairment. Adding other risk factors and their inclusion in panels assessing the risk of progression of cognitive impairment should be considered.Keywords
Funding Information
- Moscow Centre for Innovative Technologies in Healthcare (0803-4/23)
This publication has 55 references indexed in Scilit:
- Hippocampal subfield volumes in mild cognitive impairment and alzheimer’s disease: a systematic review and meta-analysisBrain Imaging and Behavior, 2023
- Association between metabolic syndrome and risk of incident dementia in UK BiobankAlzheimer's & Dementia, 2023
- Cognitive Decline Associated with Aging2023
- Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measuresAlzheimer's & Dementia, 2023
- Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer’s diseaseActa Neurologica Belgica, 2023
- Altered functional connectivity of the default mode and dorsal attention network in subjective cognitive declineJournal of Psychiatric Research, 2023
- Hippocampus-based static functional connectivity mapping within white matter in mild cognitive impairmentBrain Structure and Function, 2022
- Cognitive Reserve, Alzheimer’s Neuropathology, and Risk of Dementia: A Systematic Review and Meta-AnalysisNeuropsychology Review, 2021
- Association of Lifestyle and Genetic Risk With Incidence of DementiaJAMA, 2019
- “Mini-mental state”Journal of Psychiatric Research, 1975